bronchiolitis - Nursing Case Study

Pathophysiology

• Primary mechanism: Viral infection, most commonly by Respiratory Syncytial Virus (RSV), leads to inflammation and swelling of the bronchioles, causing obstruction and difficulty in air exchange.

• Secondary mechanism: Increased mucus production further blocks the narrowed airways, worsening airflow limitation and contributing to atelectasis or areas of lung collapse.

• Key complication: Hypoxemia can result from impaired gas exchange, leading to decreased oxygen levels in the blood, which may require supportive interventions such as supplemental oxygen therapy.

Patient Profile

Demographics:

18-month-old male, daycare attendee

History:

• Key past medical history: Previous episodes of mild bronchiolitis, eczema

• Current medications: None

• Allergies: No known allergies

Current Presentation:

• Chief complaint: Difficulty breathing and persistent cough

• Key symptoms: Wheezing, nasal flaring, retractions, reduced appetite, irritability

• Vital signs: Temperature 38.5°C, heart rate 160 bpm, respiratory rate 60 breaths per minute, oxygen saturation 89% on room air

Section 1

Initial Assessment Findings:

Upon arrival at the pediatric ward, the child is visibly distressed, with marked nasal flaring and intercostal retractions evident during respiration, indicating significant respiratory effort. Auscultation of the lungs reveals diffuse wheezing, particularly on expiration, and occasional crackles, suggesting areas of airway obstruction and possible atelectasis. The child is tachypneic with a respiratory rate remaining elevated at 60 breaths per minute, and his heart rate remains high at 160 bpm, consistent with his febrile state and increased work of breathing. Despite attempts to engage the child, he is irritable and has a reduced response to stimuli, likely secondary to hypoxemia and fatigue. The initial pulse oximetry reading remains concerning with an oxygen saturation of 89% on room air, necessitating immediate intervention.

Supplemental oxygen is administered via nasal cannula, targeting an SpO2 of greater than 92% to improve oxygenation and reduce respiratory distress. While oxygen therapy helps to alleviate some of the respiratory effort, the child still exhibits signs of respiratory distress, suggesting that further assessment and possible escalation of care may be necessary. A chest X-ray is ordered to evaluate the extent of lung involvement and to check for any secondary complications such as atelectasis or infiltrates consistent with viral pneumonia.

Laboratory tests including a complete blood count and viral panel are drawn to identify any underlying infection and to confirm the presence of RSV. The child's eczema history is considered, as it may predispose him to a heightened inflammatory response. As the team waits for diagnostic results, clinical reasoning focuses on monitoring and managing potential complications such as worsening hypoxemia or the development of secondary bacterial infection, while ensuring supportive care to maintain hydration and nutrition, given his reduced appetite. The team prepares to reassess the child's condition closely, anticipating the potential need for additional respiratory support or pharmacologic interventions.

Section 2

As the medical team continues to monitor the child closely, new diagnostic results return, providing further clarity on the clinical picture. The chest X-ray reveals bilateral patchy infiltrates, consistent with viral pneumonia, and areas of atelectasis, particularly in the right lower lobe. These findings align with the auscultation results of diffuse wheezing and occasional crackles. The viral panel confirms the presence of Respiratory Syncytial Virus (RSV), a common cause of bronchiolitis in young children. The complete blood count shows a mild leukocytosis, which could indicate a secondary bacterial infection or simply be part of the inflammatory response to the viral illness.

The child's oxygen saturation has marginally improved with supplemental oxygen, now reading at 91%, but still falls short of the target range. The persistently high respiratory rate and heart rate, coupled with ongoing irritability and fatigue, suggest that the child is struggling to meet his metabolic demands, and further intervention is necessary. The team decides to initiate high-flow nasal cannula (HFNC) therapy to provide better support for the child’s respiratory needs, aiming to improve oxygenation and reduce work of breathing. This decision is informed by the presence of atelectasis and the need for positive airway pressure to help reopen collapsed alveoli.

In anticipation of potential secondary bacterial infection, the team also considers starting empiric antibiotic therapy, although they remain cautious, weighing the risks and benefits given the viral nature of the primary infection. The child’s history of eczema is noted, and the team remains vigilant for any signs of an exaggerated inflammatory response that might complicate the clinical course. With these interventions underway, the clinical team plans for ongoing assessment of the child’s response, ready to adjust the care plan based on his evolving status.

Section 3

Over the next 24 hours, the child’s response to the initiated interventions begins to unfold. Initially, the high-flow nasal cannula (HFNC) therapy appears to provide some benefit. The child’s oxygen saturation gradually rises, stabilizing at 94%, which is within the target range. The respiratory rate decreases to 45 breaths per minute, and the accessory muscle use becomes less pronounced, suggesting a reduction in the work of breathing. However, despite these improvements, the child remains tachycardic with a heart rate of 150 beats per minute, indicating ongoing physiological stress. The persistence of fatigue and irritability prompts further evaluation to ensure no additional complications are developing.

In parallel, the team notes a concerning development in the child’s clinical status. The child’s temperature spikes to 39.5°C (103.1°F), and the leukocytosis detected earlier has progressed, with a white blood cell count now standing at 18,000/mm³. This escalation, combined with the new onset of productive cough with greenish sputum, raises suspicion for a secondary bacterial infection superimposed on the viral bronchiolitis. The decision to start empiric antibiotic therapy is revisited, and the team initiates a course of broad-spectrum antibiotics, while awaiting results from blood cultures and sputum analysis to tailor the treatment more specifically.

Given the child’s history of eczema and potential for heightened inflammatory responses, the clinical team monitors closely for any signs of allergic reactions or exacerbations of eczema that might complicate treatment. The multidisciplinary team now focuses on balancing the management of the viral and potential bacterial components of the child’s condition, while continuously reassessing the effectiveness of the HFNC therapy and the need for further respiratory support. The evolving clinical picture necessitates vigilant monitoring and readiness to adjust the care plan as new information and responses to interventions come to light.

Section 4

As the clinical team continues to monitor the child, new diagnostic results provide additional insights into the evolving condition. Blood culture results come back positive for Streptococcus pneumoniae, confirming the presence of a secondary bacterial infection. The initial choice of broad-spectrum antibiotics is deemed appropriate, but the team considers adjusting the antibiotic regimen to more specifically target the identified pathogen. In parallel, the sputum analysis corroborates the blood culture findings, displaying abundant neutrophils and the presence of pneumococci. This reinforces the need for accurate antibiotic coverage to combat the bacterial superinfection effectively.

Amidst these developments, the child's respiratory status shows signs of deterioration despite ongoing HFNC therapy. The respiratory rate increases again to 60 breaths per minute, and there is a noticeable return of accessory muscle use, indicating a resurgence in the work of breathing. Oxygen saturation begins to fluctuate, occasionally dipping to 90%, prompting concerns about adequate oxygenation. The clinical team reassesses the current respiratory support strategy and considers escalating to non-invasive positive pressure ventilation if the child's condition does not stabilize soon.

Meanwhile, the child's persistent tachycardia and elevated temperature suggest a heightened inflammatory response. The team evaluates potential allergic reactions or eczema exacerbations given the child's history, but no immediate signs are evident. Nonetheless, the interplay between the viral bronchiolitis, secondary bacterial infection, and the child's predisposed inflammatory tendencies necessitates a careful and comprehensive approach to management. The team remains vigilant, ready to adapt the treatment plan as new challenges arise, ensuring that the child receives appropriate and timely care to address both existing and potential complications.

Section 5

As the clinical team continues to manage the child's condition, they observe a change in patient status that prompts a reassessment of the current treatment plan. Despite the ongoing antibiotic therapy targeting Streptococcus pneumoniae, the child begins to exhibit increased respiratory distress, characterized by a persistent respiratory rate of 62 breaths per minute and pronounced accessory muscle use. Oxygen saturation levels are consistently fluctuating between 88% and 91%, indicating a need for more aggressive respiratory support. The child's heart rate remains elevated at 145 beats per minute, and the temperature spikes to 39.5°C, suggesting that the inflammatory response is not fully controlled.

In light of these concerning developments, the team decides to escalate respiratory support by initiating non-invasive positive pressure ventilation (NIPPV) to improve oxygenation and reduce the work of breathing. Concurrently, they adjust the antibiotic regimen to include a higher dose of amoxicillin-clavulanate, specifically targeting the pneumococcal infection more effectively. A repeat blood culture is ordered to assess the effectiveness of the antibiotic therapy and to rule out any potential resistance or new pathogens.

Additionally, the multidisciplinary team considers the overall inflammatory response and opts to administer a short course of corticosteroids to help manage the exaggerated immune response, particularly given the child's history of allergic tendencies. Regular monitoring of vital signs, blood gases, and inflammatory markers is initiated to evaluate the impact of these interventions. Through these comprehensive efforts, the team aims to stabilize the child's condition, mitigate complications, and ultimately guide the patient toward recovery.